The number one reason biopharma companies receive a warning letter from FDA is not having procedures in writing or fully followed signaling an opportunity to improve employee training practices (1).

Training and process documents previously homed on the Finance Training page have been reorganized. Information contained in formal, SuccessFactors based training can be found in the Training Matrix ...